Functional Recovery in Major Depressive Disorder: Focus on Early Optimized Treatment
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This article presents the case that a more rapid, individualized approach to treating major depressive disorder (MDD) may increase the likelihood of achieving full symptomatic and functional recovery for individual patients and that studies show it is possible to make earlier decisions about appropriateness of treatment in order to rapidly optimize that treatment. DATA SOURCES: A PubMed search was conducted using terms including major depressive disorder, early improvement, predictor, duration of untreated illness, and function. English-language articles published before September 2015 were included. Additional studies were found within identified research articles and reviews. STUDY SELECTION: Thirty antidepressant studies reporting predictor criteria and outcome measures are included in this review. DATA EXTRACTION: Studies were reviewed to extract definitions of predictors, outcome measures, and results of the predictor analysis. Results were summarized separately for studies reporting effects of early improvement, baseline characteristics, and duration of untreated depression. RESULTS: Shorter duration of the current depressive episode and duration of untreated depression are associated with better symptomatic and functional outcomes in MDD. Early improvement of depressive symptoms predicts positive symptomatic outcomes (response and remission), and early functional improvement predicts an increased likelihood of functional remission. CONCLUSIONS: The approach to treatment of depression that exhibits the greatest potential for achieving full symptomatic and functional recovery is early optimized treatment: early diagnosis followed by rapid individualized treatment. Monitoring symptoms and function early in treatment is crucial to ensuring that patients do not remain on ineffective or poorly tolerated treatment, which may delay recovery and heighten the risk of residual functional deficits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Prognosis and improved outcomes in major depression: a review
Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0460-3 · Cited by 482
Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis
Brutocao, C., Zaiem, F., Alsawas, M., Morrow, A. S., Murad, M. H., & Javed, A. (2018) · Endocrine · doi:10.1007/s12020-018-1692-3 · Cited by 251
Zheutlin, A. B., Dennis, J., Karlsson Linnér, R., Moscati, A., Restrepo, N., Straub, P., Ruderfer, D., Castro, V. M., Chen, C.-Y., Ge, T., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18091085 · Cited by 223
Oluboka, O. J., Katzman, M. A., Habert, J., McIntosh, D., MacQueen, G. M., Milev, R. V., McIntyre, R. S., & Blier, P. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx081 · Cited by 104
“An effective treatment plan adjusts to address these obstacles to optimize treatment as rapidly as possible (Culpepper et al., 2015; Habert et al., 2016).”
BackgroundInfluentialSelf-citationNew trends in personalized treatment of depression
Sampogna, G., Toni, C., Catapano, P., Rocca, B. D., Vincenzo, M. D., Luciano, M., & Fiorillo, A. (2023) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000903 · Cited by 88
Cognitive dysfunctions in depression – significance, description and treatment prospects
Czerwińska, A., & Pawłowski, T. (2020) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/105415 · Cited by 85
Erabi, H., Okada, G., Shibasaki, C., Setoyama, D., Kang, D., Takamura, M., Yoshino, A., Fuchikami, M., Kurata, A., Kato, T. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73918-z · Cited by 78
Paul, R., Andlauer, T. F. M., Czamara, D., Hoehn, D., Lucae, S., Pütz, B., Lewis, C. M., Uher, R., Müller‐Myhsok, B., Ising, M., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0524-4 · Cited by 77
Mekonen, T., Ford, S., Chan, G., Hides, L. M., Connor, J. P., & Leung, J. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.046 · Cited by 71
Oral ketamine for depression: An updated systematic review
Meshkat, S., Haikazian, S., Vincenzo, J. D. D., Fancy, F., Johnson, D. E., Chen-Li, D. C. J., McIntyre, R. S., Mansur, R. B., & Rosenblat, J. D. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2023.2169349 · Cited by 70
Self-citationFava, M., Durgam, S., Earley, W., Lu, K., Hayes, R., Laszlovszky, I., & Németh, G. (2018) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000235 · Cited by 58
Emotional blunting in patients with depression. Part I: clinical characteristics
Christensen, M. C., Ren, H., & Fagiolini, A. (2022) · Annals of General Psychiatry · doi:10.1186/s12991-022-00387-1 · Cited by 53
Minelli, A., Zampieri, E., Sacco, C., Bazzanella, R., Mezzetti, N., Tessari, E., Barlati, S., & Bortolomasi, M. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.01.070 · Cited by 53
Carrle, F. P., Hollenbenders, Y., & Reichenbach, A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1219133 · Cited by 53
Joyce, J. B., Grant, C. W., Liu, D., MahmoudianDehkordi, S., Kaddurah‐Daouk, R., Skime, M. K., Biernacka, J. M., Frye, M. A., Mayes, T. L., Carmody, T. J., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01632-z · Cited by 51
Mattingly, G. W., Ren, H., Christensen, M. C., Katzman, M. A., Polosan, M., Simonsen, K., & Hammer-Helmich, L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.824831 · Cited by 48
Self-citationFiorillo, A., Carpiniello, B., Giorgi, S. D., Pia, S. L., Maina, G., Sampogna, G., Spina, E., Tortorella, A. A. V., & Vita, A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00493 · Cited by 39
He, H., Xiang, Y., Gao, F., Bai, L., Gao, F., Fan, Y., Lyu, J., & Ma, X. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.08.009 · Cited by 39
Habtamu, K., Medhin, G., Selamu, M., Tirfessa, K., Hanlon, C., & Fekadu, A. (2019) · International Journal of Mental Health Systems · doi:10.1186/s13033-019-0305-8 · Cited by 38
Christensen, M. C., McIntyre, R. S., Florea, I., Loft, H., & Fagiolini, A. M. (2021) · CNS Spectrums · doi:10.1017/s1092852921000936 · Cited by 36
Self-citationCameron, S., Weston–Green, K., & Newell, K. A. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03199-x · Cited by 33
Early-diagnosis of major depressive disorder: From biomarkers to point-of-care testing
Zhang, X., Zhang, Z., Diao, W., Zhou, C., Song, Y., Wang, R., Luo, X., & Liu, G. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116904 · Cited by 33
Solidão como variável preditora na depressão em adultos
Barroso, S. M., Baptista, M. N., & Zanon, C. (2018) · Estudos Interdisciplinares em Psicologia · doi:10.5433/2236-6407.2018v9n3suplp26 · Cited by 30
Baune, B. T., Florea, I., Ebert, B., Touya, M., Ettrup, A., Hadi, M., & Ren, H. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s325954 · Cited by 26
Karvelis, P., Charlton, C. E., Allohverdi, S. G., Bedford, P., Hauke, D. J., & Diaconescu, A. O. (2022) · Network Neuroscience · doi:10.1162/netn_a_00233 · Cited by 26
Funatsuki, T., Ogata, H., Tahara, H., Shimamoto, A., Takekita, Y., Koshikawa, Y., Nonen, S., Higasa, K., Kinoshita, T., & Kato, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512199 · Cited by 25
Christensen, M. C., Ren, H., & Fagiolini, A. M. (2022) · Annals of General Psychiatry · doi:10.1186/s12991-022-00392-4 · Cited by 24
Kato, M., Ogata, H., Tahara, H., Shimamoto, A., Takekita, Y., Koshikawa, Y., Nishida, K., Nonen, S., Higasa, K., & Kinoshita, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073873 · Cited by 23
Arnaud, A. M., Suthoff, E. D., Stenson, K., WERNEBURG, B. G., Hodgkins, P., Bonthapally, V., Jonas, J. M., Meyer, K. L., & O’Day, K. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.02.027 · Cited by 23
The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder
Arnaud, A. M., Suthoff, E. D., Tavares, R. M., Zhang, X., & Ravindranath, A. J. (2021) · PharmacoEconomics · doi:10.1007/s40273-021-01021-w · Cited by 21
Treating depression in clinical practice: new insights on the multidisciplinary use of trazodone
Albert, U., Tomasetti, C., Marra, C., Neviani, F., Pirani, A., Taddeo, D., Zanetti, O. O., & Maina, G. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1207621 · Cited by 20
Zhou, Q., Wu, Z., Wang, Y., Liu, X., Chen, J., Wang, Y., Su, Y., Zhang, C., Peng, D., Hong, W., et al. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13030 · Cited by 20
Effect of agomelatine 25–50 mg on functional outcomes in patients with major depressive disorder
Kennedy, S. H., Heun, R., Аведисова, А. С., Ahokas, A., Olivier, V., Picarel-Blanchot, F., & de Bodinat, C. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.05.060 · Cited by 19
Self-citationZhu, L., Ferries, E., Suthoff, E. D., Namjoshi, M. A., & Bera, R. B. (2022) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2022.28.11-a.s1 · Cited by 19
Clayton, A. H., Suthoff, E. D., Jain, R., Kosinski, M. R., Fridman, M., Deligiannidis, K. M., Meltzer-Brody, S. E., Chen, S., Gervitz, L. M., Huang, M., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.268 · Cited by 18
Papalexi, E., Galanopoulos, A., Kontis, D., Markopoulou, M., Balta, G., Karavelas, E., Panagiotidis, P., Vlachos, T., & Ettrup, A. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04109-5 · Cited by 16
McIntyre, R. S., Prieto, R., Schepman, P., Yeh, Y.-C., Boucher, M., Shelbaya, A., Chambers, R., Gao, X., & Pappadopulos, E. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1652053 · Cited by 15
Self-citationClinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder
Christensen, M. C., McIntyre, R. S., Adair, M., Florea, I., Loft, H., & Fagiolini, A. M. (2023) · CNS Spectrums · doi:10.1017/s1092852923002249 · Cited by 15
Self-citationKato, M., Asami, Y., Wajsbrot, D., Wang, X., Boucher, M., Prieto, R., & Pappadopulos, E. A. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.06.011 · Cited by 15
In pursuit of full recovery in major depressive disorder
Vicent-Gil, M., Serra-Blasco, M., Navarra‐Ventura, G., Trujols, J., Balanzá‐Martínez, V., Portella, M. J., & Cardoner, N. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01487-5 · Cited by 15
Menculini, G., Verdolini, N., Brufani, F., Pierotti, V., Cirimbilli, F., Buò, A. D., Spollon, G., Giorgi, F. D., Sciarma, T., Tortorella, A. A. V., et al. (2021) · Medicina · doi:10.3390/medicina57050459 · Cited by 15
Lee, D. Y., Cho, Y. H., Kim, M.-S., Jeong, C., Cha, J. M., Won, G. H., Noh, J. S., Son, S. J., & Park, R. W. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.10 · Cited by 15
Rothman, B., Slomkowski, M., Speier, A., Rush, A. J., Trivedi, M. H., Lawson, E., Fahmy, M., Carpenter, D., Chen, D., & Forbes, A. (2024) · JMIR Research Protocols · doi:10.2196/56960 · Cited by 13
Katzman, M. A., Therrien, F., MacKenzie, E. M., Wang, F., de Jong-Laird, A., & Boucher, M. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.021 · Cited by 12
Self-citationBenoit, J. R. A., Dursun, S. M., Greiner, R., Cao, B., Brown, M. R. G., Lam, R. W. M., Cowen, P., & Greenshaw, A. J. (2021) · The Canadian Journal of Psychiatry · doi:10.1177/07067437211037141 · Cited by 12
Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects
Mora, F., Ramos‐Quiroga, J. A., Baca‐García, E., Crespo, J. M., Gutiérrez-Rojas, L., Madrazo, A., Pérez-Costillas, L., Sáiz, P. A., Tordera, V., & Vieta, E. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1623659 · Cited by 11
Martins-Correia, J., Fernandes, L. A., Kenny, R. P. W., Salas, B., Karmani, S. J., Inskip, A., Pearson, F., & Watson, S. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.06.099 · Cited by 11
Hühne, V., Chacur, C., de Oliveira, M. V. S., Fortes, P. P., de Menezes, G. M. B., & Fontenelle, L. F. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2265066 · Cited by 11
Takasu, K., Yawata, Y., Tashima, R., Aritomi, H., Shimada, S., Onodera, T., Taishi, T., & Ogawa, K. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1274459 · Cited by 11
Cost-Effectiveness of a Web-Based Program for Residual Depressive Symptoms: Mindful Mood Balance
Boggs, J. M., Ritzwoller, D. P., Beck, A. L., Dimidjian, S., & Segal, Z. V. (2021) · Psychiatric Services · doi:10.1176/appi.ps.202000419 · Cited by 11
Zhou, J., Yang, J., Zhu, X., Zghoul, T., Feng, L., Chen, R., & Wang, G. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320938556 · Cited by 11
Qu, N., Zhang, S.-F., Xia, B., Xie, J., Wang, X., Liu, J., Xiong, J., Na, R., Wang, Y., Tian, Q., et al. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.10.002 · Cited by 11
Saavedra, J. E., & Galea, J. T. (2020) · Community Mental Health Journal · doi:10.1007/s10597-020-00639-y · Cited by 11
Early optimized pharmacological treatment in patients with depression and chronic pain
Oluboka, O. J., Katzman, M. A., Habert, J., Khullar, A., Oakander, M. A., McIntosh, D., McIntyre, R. S., Soares, C. N., Lam, R. W. M., Klassen, L. J., et al. (2022) · CNS Spectrums · doi:10.1017/s1092852922000128 · Cited by 10
Self-citationBlodgett, J. M., Norris, T., Pereira, S. M. P., & Hamer, M. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.12.084 · Cited by 9
Baldwin, D. S., Adair, M., Micheelsen, A., Åström, D. O., & Reines, E. H. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2313108 · Cited by 9
Social Media App Usage in Relation with PHQ-9 Depression Scores during the COVID-19 Pandemic
Mulansky, L., Pryss, R. C., Cohrdes, C., Baumeister, H., & Beierle, F. (2022) · ACM International Joint Conference on Pervasive and Ubiquitous Computing (UbiComp) · doi:10.1145/3544793.3563411 · Cited by 9
Serafini, G., Gonda, X., Monacelli, F., Pardini, M., Pompili, M., Rihmer, Z., & Amore, M. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.077 · Cited by 9
Dimensions and Predictors of Personal Recovery in Major Depression
Luciano, M., Carmassi, C., & Albert, U. (2022) · Comprehensive approach to psychiatry · doi:10.1007/978-3-030-98301-7_13 · Cited by 8
Categorical improvement in functional impairment in depressed patients treated with desvenlafaxine
Soares, C. N., Zhang, M., & Boucher, M. (2017) · CNS Spectrums · doi:10.1017/s1092852917000633 · Cited by 8
Arnaud, A. M., & Bonthapally, V. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.01.059 · Cited by 8
Almeida, S. S., Christensen, M. C., Simonsen, K., & Adair, M. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221132468 · Cited by 7
Gillespie, C. F., Szabo, S. T., & Nemeroff, C. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00036-9 · Cited by 7
Silberbauer, L., Eggerstorfer, B., Michenthaler, P., Reichel, S., Stimpfl, T., Vanicek, T., Naderi‐Heiden, A., Kasper, S. F., Lanzenberger, R. R., & Gryglewski, G. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120466 · Cited by 7
Predictors of recurrence in a sample of 508 outpatients with major depressive disorder
Serafini, G., Santi, F., Gonda, X., Aguglia, A., Fiorillo, A., Pompili, M., Carvalho, A. F., & Amore, M. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.04.015 · Cited by 6
Polosan, M., Rabbani, M., Christensen, M. C., Simonsen, K., & Ren, H. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s374635 · Cited by 6
Silva, R. C., Dattilo, V., Perusi, G., Mazzelli, M., Maffioletti, E., Bazzanella, R., Bortolomasi, M., Cattaneo, A., Gennarelli, M., & Minelli, A. (2023) · Journal of EMDR Practice and Research · doi:10.1891/emdr-2023-0019 · Cited by 5
Zamfirache, F., Dumitru, C., Trandafir, D. M., Bratu, A. T., & Radu, B. M. (2025) · Applied Sciences · doi:10.3390/app15074020 · Cited by 5
Inoue, T., Fujimoto, S., Marumoto, T., Kitagawa, T., Ishida, K., Nakajima, T., Moriguchi, Y., Fujikawa, K., & Watanabe, K. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s340309 · Cited by 5
Cha, D. S., Kleine, N., Teopiz, K. M., Vincenzo, J. D. D., Ho, R., Galibert, S. L., Samra, A., Zilm, S. P. M., Cha, R. H., d’Andrea, G., et al. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2298340 · Cited by 4
Self-citationYang, L., Su, Y., Dong, S., Wu, T., Zhang, Y., Qiu, H. X., Gu, W., Qiu, H. X., Xu, Y., Wang, J., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.954973 · Cited by 4
New goals for depression therapy
Петрова, Н. Н. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212211157 · Cited by 4
Robin, A., Thomas-Ollivier, V., Sauvaget, A., Péré, M., & Bulteau, S. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.03.050 · Cited by 4
Tow, K. E., Caputi, P., Zentrich, G., Deane, F. P., Thyer, L., Simpson, P., & Risi, A. (2025) · Cogent Psychology · doi:10.1080/23311908.2025.2594286 · Cited by 3
Oluboka, O. J., Habert, J., Khullar, A., Robinson, D. J., Katzman, M. A., Klassen, L. J., Soares, C., Chokka, P. R., Oakander, M. A., McIntyre, R. S., et al. (2025) · CNS Spectrums · doi:10.1017/s1092852925000276 · Cited by 3
Self-citationCiccone, C. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-60912-8.00006-3 · Cited by 3
Soares, C. N., Wajsbrot, D., & Boucher, M. (2019) · CNS Spectrums · doi:10.1017/s1092852919000828 · Cited by 3
González-Pinto, A. M. (2020) · Psiquiatría Biológica · doi:10.1016/j.psiq.2020.01.001 · Cited by 3
Yoshioka, K., & Rossetto, A. (2024) · International Journal of Mental Health · doi:10.1080/00207411.2024.2320447 · Cited by 3
Watanabe, K., Sumiyoshi, T., Kato, M., Kikuchi, T., Moriguchi, Y., Åström, D. O., & Christensen, M. C. (2025) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2025.100955 · Cited by 2
Grant, H., Vitkauskaite, E., Kalniunas, A., & Pappa, S. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1643042 · Cited by 2
Chokka, P. R., Hammer-Helmich, L., Schmidt, S. N., Hubert, M., Reines, E. H., & Grande, I. (2025) · Current Medical Research and Opinion · doi:10.1080/03007995.2025.2503976 · Cited by 2
Self-citationCurrent methods for predicting therapeutic response in patients with depressive disorders
Алексеевич, Г. С., Ivanova, S. А., & Bokhan, N. A. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212202115 · Cited by 2
The Use of Pharmacogenomics in Mental Health
Walker, T. K., Dodson, C., & Bousman, C. (2025) · Nursing Clinics of North America · doi:10.1016/j.cnur.2024.12.006 · Cited by 2
Personal Recovery in People with Mental Disorders: The Achievement of a Meaningful Life
Pellegrini, L., & Albert, U. (2024) · Sustainable development goals series · doi:10.1007/978-3-031-70165-8_21 · Cited by 2
Philippi, R., & Correa, R. (2022) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272022000300337 · Cited by 2
Kim, B., Chae, M., Seo, H., Jeong, J., Park, S., Jeong, I., Kim, Y., Kim, Y., Jung, T., Lee, T. H., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122076 · Cited by 2
Kapadia, S., Zhang, Z., Ardic, F. C., Patel, M., Thase, M. E., & Papakostas, G. I. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf074 · Cited by 2
Kim, J.-W., Yoon, H., Jung, D., Oh, W., Choi, D., Yoon, S.-H., Kim, D.-J., Lee, S.-Y., Kim, B.-N., & Yang, C.-M. (2026) · IEEE Access · doi:10.1109/access.2026.3727881 · Cited by 1
Recovery-Oriented Treatments in Major Depressive Disorder
Sampogna, G., Vincenzo, M. D., Giallonardo, V., Luciano, M., & Fiorillo, A. (2022) · Comprehensive approach to psychiatry · doi:10.1007/978-3-030-98301-7_14 · Cited by 1
Diep, T. T., Thao, H. P., Luận, T. C., Huong, N. T., & Lien, T. T. X. (2025) · Journal of Public Mental Health · doi:10.1108/jpmh-01-2025-0004 · Cited by 1
Diagnosis and treatment of depression according to the functional recovery paradigm
Михайлович, У. Г. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-5-79-86 · Cited by 1
Liu, J., Gao, S., Liu, B., Ju, Y., Liao, M., Zhang, L., Li, Z., Zhang, Q., Zhao, X., Tang, H., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103626 · Cited by 1
Portela, R., Brister, T. S., Mattingly, G. W., Drissen, T., & Bowrey, H. E. (2026) · Annals of General Psychiatry · doi:10.1186/s12991-026-00662-5 · Cited by 1
Accidents ischémiques et dépression
Drapier, D. (2022) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2022.04.012 · Cited by 1
Morgunova, A. (2024) · eScholarship@McGill (McGill) · doi:10.82308/15433 · Cited by 1
Wichniak, A., Iwański, M., & Mitrić, M. (2026) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/197146 · Cited by 1
Wang, H., Wang, L., & Xiao, J. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001231
Fazzito, M. L., Gonzalez, J. J., Fiorentini, L., Leiman, M., Pérez, A. C., Costanzo, E. Y., Villarreal, M. F., & Guinjoan, S. M. (2021) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2021.100082
Biomarkers of response to rapid-acting antidepressants
Cano, M., & Cardoner, N. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.06.007
Metadata
- Authors
- Habert, J., Katzman, M. A., Oluboka, O. J., McIntyre, R. S., McIntosh, D., MacQueen, G. M., Khullar, A., Milev, R. V., Kjernisted, K. D., Chokka, P. R., & Kennedy, S. H.
- Affiliations
- University of Toronto (CA)
- START Clinic (CA)
- University of Calgary (CA)
- University of British Columbia (CA)
- University of Alberta (CA)
- Queen's University (CA)
- Corresponding author
- Habert, Jeffrey
- ORCID
- Venue
- The Primary Care Companion For CNS Disorders
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2016-09-01
- Volume
- 18
- Issue
- 5
- ISSN
- 2155-7772 (ISSN-L)
- 2155-7780
- OpenAlex
- W2513251082
- Cited by
- 84
- References
- 0
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 9 · 2023: 9 · 2022: 18 · 2021: 10 · 2020: 5 · 2019: 12 · 2018: 6 · 2017: 3
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Primary Care Companion For CNS Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- major depressive disorder, functional recovery, early improvement, depressive episode duration, predictors of treatment response, antidepressant treatment, functional remission, personalized treatment
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Female, Humans, Male, Treatment Outcome, Early Diagnosis, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.